ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced that it has closed the equity financing it announced on June 3, 2013 and received gross proceeds of $9,057,966. BioTime intends to use the net proceeds from the sale of its common shares and warrants for working capital and other general corporate purposes, and may invest […]
Mountain View, CA and Ann Arbor, MI ——Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc.,and Rubicon Genomics, Inc. announced today that they have partnered to integrate Clontech’s SMART technology with Rubicon’sThruPLEX technology to increase the efficiency and quality of RNA sample preparation for a variety of next generation sequencing (NGS) applications. The launch […]
Paris, – Cellectis (NYSE Alternext: ALCLS), the global genome engineering specialist, announced today that Luc Mathis, Cellectis plant sciences CEO, has been elected to the Board of Directors of the French Association for Plantbiotechnology (Association Française des Biotechnologies Végétales, AFBV). The French Association for Plant biotechnology (AFBV) is an independent NGO established in 2009. Its […]
Madison, WI – Methyltransferases are key players in epigenetic control of gene expression and have become the targets of intensive public and private drug discovery efforts. Unfortunately, the first step in developing epigenetic drugs – identification of specific inhibitors for target enzymes – has been plagued by problems in getting methyltransferase enzymes to function correctly […]
Paris, – Cellectis (NYSE Alternext: ALCLS), the global genome engineering specialist, announced today that Luc Mathis, Cellectis plant sciences CEO, has been elected to the Board of Directors of the French Association for Plant Biotechnology (Association Française des Biotechnologies Végétales, AFBV). The French Association for Plant Biotechnology (AFBV) is an independent NGO established in 2009. […]
BEVERLY, Massachusetts,. North Shore InnoVentures, (NSIV) one of New England’s leading technology incubators and business accelerators, announced today that six new startup companies in the cleantech and life sciences sectors have joined as members since March 2013, for a total of 21 companies now in the program. “This is a record number of companies joining […]
Menlo Park, Calif. — DNA2.0, the leading bioengineering solutions provider, today introduced the Electra Vector System, a universal cloning system for simple, scarless cloning. The Electra system is completely free from licensing restrictions and provides researchers from a large variety of disciplines a much-needed advantage to current cloning methodology. Systems that facilitate easy movement of […]
MADISON, WIS.,–Cellular Dynamics International (CDI) today announced that it has expanded its MyCell® Products line, offering access to a number of human disease models and licensing key genetic engineering patents from Life Technologies and Sigma-Aldrich. CDI’s MyCell Products include custom cell products manufactured using induced pluripotent stem cell (iPSC) technology to make stem cells or […]
MADISON, WIS.,– Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that it has filed a registration statement on June 3, 2013, on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of its common […]
BELLSHILL, SCOTLAND,: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, has announced the release of its 2013/14 Product Guide. The new guide, complete with brand new products and associated application notes, is a comprehensive resource for researchers and manufacturers in oligonucleotide biochemistry, including oligo synthesis and modification. Valuably, this guide covers an […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
